protein | BASIC | Visual Basic | Protein subunit | Protein-protein interaction | Basic Instinct | Hfq protein | protein domain | The Basic School | Protein-protein_interaction | Protein Data Bank | Visual Basic for Applications | RNA-binding protein | BBC BASIC | basic training | Visual Basic .NET | STOS BASIC | Promyelocytic leukemia protein | G protein | Wiskott–Aldrich syndrome protein | Protein G | protein dimer | Protein A | Herb (from Basic Equipment) | GW-BASIC | G-BASIC | Family BASIC | C-reactive protein | Bone morphogenetic protein 2 | Basic Training |
Results from rat hippocampal gene chip data after acute administration of tetrahydrocannabinol (THC) showed an increase in the expression of transcripts encoding myelin basic protein, endoplasmic proteins, cytochrome oxidase, and two cell adhesion molecules: NCAM, and SC1; decreases in expression were seen in both calmodulin and ribosomal RNAs (Kittler et al., 2000).
Medwell Capital obtained an exclusive worldwide license to proprietary technology developed at the MS Patient Care and Research Clinic at the University of Alberta for the treatment of MS. The compound, dirucotide (MBP8298), is a synthetic myelin basic protein peptide composed of 17 amino acids which is intravenously injected (every six months) into MS patients as a therapeutic treatment.